TurnerTrends Stock Rating Report for BNVI
Data valid for week beginning July 14, 2008
|
BNVI [News]
|
Bionovo Inc
|
Company Profile
"Bionovo, Inc. engages in the discovery and development of drugs in the areas of women's health and cancer primarily in the United States. The company focuses on developing drugs to treat breast and ovarian cancers, and for menopause. Its lead drug candidate includes MF101, a receptor sub-type selective estrogen receptor modulator for the treatment of vasomotor symptoms of menopause. Bionovo's other products in development includes BZL101, an orally delivered anti-cancer agent for advanced breast cancer- and VG101, for the treatment of post-menopausal vulvar-vaginal dryness. It has collaborations with the University of California at San Francisco- University of California at Berkeley- University of California at Davis- University of Texas, Southwestern- and University of Colorado Health Sciences College. The company was founded in 2002 and is based in Emeryville, California."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Mon, 30 Jun 2008 18:16:09 Etc/GMT | Russell 2000 adds 53 health care companies (AP) | | Mon, 16 Jun 2008 11:40:00 Etc/GMT | Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs (PR Newswire) | | Mon, 16 Jun 2008 11:32:00 Etc/GMT | Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation (PR Newswire) | | Mon, 16 Jun 2008 11:31:00 Etc/GMT | Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta (PR Newswire) | | Mon, 16 Jun 2008 11:30:00 Etc/GMT | Bionovo's Drug Candidate Shows In Vivo Safety and Efficacy in the Treatment of Vaginal Atrophy (PR Newswire) | | Thu, 5 Jun 2008 12:00:00 Etc/GMT | Bionovo Develops a High Throughput LC-MS/MS Method for Simultaneous Quantification of Multiple Bioactive Compounds (PR Newswire) | | Mon, 2 Jun 2008 14:55:00 Etc/GMT | Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles (PR Newswire) | | Tue, 20 May 2008 13:32:24 Etc/GMT | BIONOVO INC Financials (EDGAR Online Financials) | | Mon, 12 May 2008 15:14:21 Etc/GMT | New Star Analyst Rankings for BIONOVO INC (StarMine) | | Mon, 12 May 2008 10:04:44 Etc/GMT | BIONOVO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Fri, 9 May 2008 22:05:08 Etc/GMT | Bionovo reports $3.9 million loss in Q1 (at bizjournals.com) | | Fri, 9 May 2008 20:59:05 Etc/GMT | BIONOVO INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online) | | Fri, 9 May 2008 20:30:00 Etc/GMT | Bionovo Reports First Quarter 2008 Financial Results (PR Newswire) | | Wed, 9 Apr 2008 10:01:03 Etc/GMT | BIONOVO INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | | Mon, 17 Mar 2008 21:30:37 Etc/GMT | BIONOVO INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) | | Thu, 13 Mar 2008 18:59:31 Etc/GMT | BIONOVO INC Files SEC form 10-K, Annual Report (EDGAR Online) | | Mon, 7 Jan 2008 19:49:36 Etc/GMT | BIONOVO INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements (EDGAR Online) | | Mon, 3 Dec 2007 17:26:03 Etc/GMT | Friday's Biggest Stock Stars (at Motley Fool) | | Fri, 30 Nov 2007 11:02:27 Etc/GMT | BIONOVO INC Files SEC form 8-K/A, Change in Directors or Principal Officers (EDGAR Online) | | Thu, 29 Nov 2007 22:25:00 Etc/GMT | BIONOVO INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | News provided by Yahoo! Finance |
|
